SAN DIEGO--(BUSINESS WIRE)--Inovio Biomedical Corporation (NYSE Alternext:INO), a leader in enabling the development of DNA vaccines using electroporation-based DNA delivery, announced today that Chin-Cheong Chong has resigned from the Company’s board of directors.